126 related articles for article (PubMed ID: 33084720)
1. Longitudinal biometal accumulation and Ca isotope composition of the Göttingen minipig brain.
Mahan B; Antonelli MA; Burckel P; Turner S; Chung R; Habekost M; Jørgensen AL; Moynier F
Metallomics; 2020 Oct; 12(10):1585-1598. PubMed ID: 33084720
[TBL] [Abstract][Full Text] [Related]
2. Exploring the K isotope composition of Göttingen minipig brain regions, and implications for Alzheimer's disease.
Mahan B; Tacail T; Lewis J; Elliott T; Habekost M; Turner S; Chung R; Moynier F
Metallomics; 2022 Dec; 14(12):. PubMed ID: 36416864
[TBL] [Abstract][Full Text] [Related]
3. The distribution profile and oxidation states of biometals in APP transgenic mouse brain: dyshomeostasis with age and as a function of the development of Alzheimer's disease.
Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Zhao Y; Feng W; Chai Z
Metallomics; 2012 Mar; 4(3):289-96. PubMed ID: 22301945
[TBL] [Abstract][Full Text] [Related]
4. Examining the homeostatic distribution of metals and Zn isotopes in Göttingen minipigs.
Mahan B; Moynier F; Jørgensen AL; Habekost M; Siebert J
Metallomics; 2018 Sep; 10(9):1264-1281. PubMed ID: 30128473
[TBL] [Abstract][Full Text] [Related]
5. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
Solovyev N; El-Khatib AH; Costas-Rodríguez M; Schwab K; Griffin E; Raab A; Platt B; Theuring F; Vogl J; Vanhaecke F
J Biol Chem; 2021; 296():100292. PubMed ID: 33453282
[TBL] [Abstract][Full Text] [Related]
6. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
[TBL] [Abstract][Full Text] [Related]
7. Stable Isotope Composition of Metal Elements in Biological Samples as Tracers for Element Metabolism.
Tanaka YK; Hirata T
Anal Sci; 2018; 34(6):645-655. PubMed ID: 29887552
[TBL] [Abstract][Full Text] [Related]
8. Identification of Cerebral Metal Ion Imbalance in the Brain of Aging
Braidy N; Poljak A; Marjo C; Rutlidge H; Rich A; Jugder BE; Jayasena T; Inestrosa NC; Sachdev PS
Front Aging Neurosci; 2017; 9():66. PubMed ID: 28405187
[TBL] [Abstract][Full Text] [Related]
9. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
[TBL] [Abstract][Full Text] [Related]
10. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
Xian-hui D; Wei-juan G; Tie-mei S; Hong-lin X; Jiang-tao B; Jing-yi Z; Xi-qing C
J Trace Elem Med Biol; 2015 Apr; 30():118-23. PubMed ID: 25575693
[TBL] [Abstract][Full Text] [Related]
12. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology.
Maynard CJ; Cappai R; Volitakis I; Cherny RA; Masters CL; Li QX; Bush AI
J Inorg Biochem; 2006 May; 100(5-6):952-62. PubMed ID: 16574231
[TBL] [Abstract][Full Text] [Related]
13. Impact of aging on copper isotopic composition in the murine brain.
Lahoud E; Moynier F; Luu TH; Mahan B; Borgne ML
Metallomics; 2024 May; 16(5):. PubMed ID: 38289854
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
Price KA; Crouch PJ; White AR
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
[TBL] [Abstract][Full Text] [Related]
15. Biological fractionation of stable Ca isotopes in Göttingen minipigs as a physiological model for Ca homeostasis in humans.
Heuser A; Eisenhauer A; Scholz-Ahrens KE; Schrezenmeir J
Isotopes Environ Health Stud; 2016 Dec; 52(6):633-48. PubMed ID: 26999569
[TBL] [Abstract][Full Text] [Related]
16. Metals and amyloid-beta in Alzheimer's disease.
Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
[TBL] [Abstract][Full Text] [Related]
17. Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.
Xie F; Peng F
J Alzheimers Dis; 2017; 59(2):527-536. PubMed ID: 28671127
[TBL] [Abstract][Full Text] [Related]
18. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
Kim N; Lee HJ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
[TBL] [Abstract][Full Text] [Related]
19. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
20. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
